Editorial: Targeted Subcellular Delivery of Anti-cancer Agents

David A Jans¹, Alexander S Sobolev^{2

3}

Affiliations

¹ Department of Biochemistry and Molecular Biology, Nuclear Signalling Laboratory, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
² Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
³ Faculty of Biology, M. V. Lomonosov Moscow State University, Moscow, Russia.

Editorial

David A Jans et al. Front Pharmacol. 2019.

. 2019 Jan 22:9:1577.

doi: 10.3389/fphar.2018.01577. eCollection 2018.

David A Jans¹, Alexander S Sobolev^{2

3}

¹ Department of Biochemistry and Molecular Biology, Nuclear Signalling Laboratory, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
² Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
³ Faculty of Biology, M. V. Lomonosov Moscow State University, Moscow, Russia.

No abstract available

Keywords: compartmentalization; drug delivery; mitochondrial targeting; nuclear targeting; organelles.

Comment on

Editorial on the Research Topic Targeted Subcellular Delivery of Anti-cancer Agents

1. Franchin C., Borgo C., Zaramella S., Cesaro L., Arrigoni G., Salvi M., et al. . (2017). Exploring the CK2 paradox: restless, dangerous, dispensable. Pharmaceuticals 10:E11. 10.3390/ph10010011 - DOI - PMC - PubMed
1. Glover D. J., Ng S. M., Mechler A., Martin L. L., Jans D. A. (2009). Multifunctional protein nanocarriers for targeted nuclear gene delivery in non-dividing cells. FASEB J. 23, 2996–3006. 10.1096/fj.09-131425 - DOI - PubMed
1. Kuusisto H., Jans D. A. (2015). Hyper-dependence of breast cancer cell types on the nuclear transporter Importin β1. Biochim. Biophys. Acta 1853, 1870–1878. 10.1016/j.bbamcr.2015.05.002 - DOI - PubMed
1. Luster M., Clarke S. E., Dietlein M., Lassmann M., Lind P., Oyen W. J. G., et al. . (2008). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur. J. Nucl. Med. Mol. Imaging 35, 1941–59. 10.1007/s00259-008-0883-1 - DOI - PubMed
1. Pouton C. W., Wagstaff K. M., Roth D. M., Jans D. A. (2007). Targeted delivery to the nucleus. Adv.Drug Deliv. Rev. 59, 698–717. 10.1016/j.addr.2007.06.010 - DOI - PubMed